André Veillette
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
André Veillette has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Sylvain Latour
Laboratory of Lymphocyte Activation and Susceptibility To EBV Infection, Inserm UMR 1163, Institut Imagine, Paris, France
3 shared publications Dominique Davidson
McGill Cancer Centre, McGill University, Montréal, Québec, Canada H3G 1Y6
2 shared publicationsDavid Soussou
From the tOaMcGill Cancer Centre and the Departments of tObBiochemistry, tOcMedicine, and tOdOncology, McGill University, Montréal, Québec H3G 1Y6, and the tOeDepartments of Medicine and Oncology, Montreal General Hospital, Montréal, Québec H3G 1A4, Canada
1 shared publicationEric Thibaudeau
From the ‡McGill Cancer Centre and the Departments of §Biochemistry, ¶Medicine, and ‖Oncology, McGill University, Montréal, Québec, Canada H3G 1Y6 and the Departments of **Medicine and Oncology, Montreal General Hospital, Montréal, Québec, Canada H3G 1A4
1 shared publicationFrançois G. Gervais
From the tOaMcGill Cancer Centre and the Departments of tObBiochemistry, tOcMedicine, and tOdOncology, McGill University, Montréal, Québec H3G 1Y6, and the tOeDepartments of Medicine and Oncology, Montreal General Hospital, Montréal, Québec H3G 1A4, Canada
1 shared publicationJean-François Cloutier
McGill Cancer Centre, McGill University, Montréal, Québec, Canada H3G 1Y6
1 shared publication
Latest Publications
- Open Access
- 15 November 1999
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 190 (10) , 1527-1534
Clnk, a Novel Slp-76–Related Adaptor Molecule Expressed in Cytokine-Stimulated Hemopoietic Cells
We have identified a novel Src homology 2 domain–containing leukocyte protein of 76 kD (SLP-76)–related molecule which we have termed Clnk (for cytokine-dependent hemopoietic cell linker). Unlike its relatives SLP-76 and B cell linker protein (Blnk), Clnk is not expressed uniformly within a given hemopoietic cell lineage. Even though it can be detected in several cell types, including T cells, natural killer cells, and mast cells, its expression seems to be strictly dependent on sustained exposure to cytokines such as interleukin (IL)-2 and IL-3. Strong support for the notion that Clnk is involved in immunoreceptor signaling was provided by the observation that it inducibly associated with at least one tyrosine-phosphorylated polypeptide (p92) in response to immunoreceptor stimulation. Moreover, transient expression of Clnk caused an increase in immunoreceptor-mediated signaling events in a T cell line. Taken together, these results show that Clnk is a novel member of the SLP-76 family selectively expressed in cytokine-stimulated hemopoietic cells. Furthermore, they suggest that Clnk may be involved in a cross-talk mechanism between cytokine receptor and immunoreceptor signaling.
- 15 November 1999
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 190 (10) , 1527-1534
Open AccessClnk, a Novel Slp-76–Related Adaptor Molecule Expressed in Cytokine-Stimulated Hemopoietic Cells
We have identified a novel Src homology 2 domain–containing leukocyte protein of 76 kD (SLP-76)–related molecule which we have termed Clnk (for cytokine-dependent hemopoietic cell linker). Unlike its relatives SLP-76 and B cell linker protein (Blnk), Clnk is not expressed uniformly within a given hemopoietic cell lineage. Even though it can be detected in several cell types, including T cells, natural killer cells, and mast cells, its expression seems to be strictly dependent on sustained exposure to cytokines such as interleukin (IL)-2 and IL-3. Strong support for the notion that Clnk is involved in immunoreceptor signaling was provided by the observation that it inducibly associated with at least one tyrosine-phosphorylated polypeptide (p92) in response to immunoreceptor stimulation. Moreover, transient expression of Clnk caused an increase in immunoreceptor-mediated signaling events in a T cell line. Taken together, these results show that Clnk is a novel member of the SLP-76 family selectively expressed in cytokine-stimulated hemopoietic cells. Furthermore, they suggest that Clnk may be involved in a cross-talk mechanism between cytokine receptor and immunoreceptor signaling.
- Open Access
- 1 May 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (20) , 14392-14399
Interactions of CD45-associated Protein with the Antigen Receptor Signaling Machinery in T-lymphocytes
- 1 May 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (20) , 14392-14399
Open AccessInteractions of CD45-associated Protein with the Antigen Receptor Signaling Machinery in T-lymphocytes
- Open Access
- 4 January 1999
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 189 (1) , 111-121
Cooperative Inhibition of T-Cell Antigen Receptor Signaling by a Complex between a Kinase and a Phosphatase
Antigen receptor–triggered T-cell activation is mediated by the sequential action of the Src and Syk/Zap-70 families of protein tyrosine kinases (PTKs). Previously, we reported that another PTK termed p50csk was a potent negative regulator of T-cell receptor (TCR) signaling because of its ability to inactivate Src-related kinases. This inhibitory effect required the catalytic activity of Csk, as well as its Src homology (SH)3 and SH2 domains. Subsequent studies uncovered that, via its SH3 domain, p50csk was associated with PEP, a proline-enriched protein tyrosine phosphatase (PTP) of unknown function expressed in hemopoietic cells. Herein, we have attempted to identify the role of the Csk-PEP complex in T lymphocytes. The results of our experiments showed that, like Csk, PEP was a strong repressor of TCR signaling. This property was dependent on the phosphatase activity of PEP, as well as on the sequence mediating its binding to p50csk. Through reconstitution experiments in Cos-1 cells, evidence was obtained that Csk and PEP act synergistically to inhibit protein tyrosine phosphorylation by Src-related kinases, and that this effect requires their association. Finally, experiments with a substrate-trapping mutant of PEP suggested that PEP functions by dephosphorylating and inactivating the PTKs responsible for T-cell activation. In addition to giving novel insights into the mechanisms involved in the negative regulation of T-cell activation, these findings indicate that the association of an inhibitory PTK with a PTP constitutes a more efficient means of inhibiting signal transduction by Src family kinases in vivo.
- 4 January 1999
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 189 (1) , 111-121
Open AccessCooperative Inhibition of T-Cell Antigen Receptor Signaling by a Complex between a Kinase and a Phosphatase
Antigen receptor–triggered T-cell activation is mediated by the sequential action of the Src and Syk/Zap-70 families of protein tyrosine kinases (PTKs). Previously, we reported that another PTK termed p50csk was a potent negative regulator of T-cell receptor (TCR) signaling because of its ability to inactivate Src-related kinases. This inhibitory effect required the catalytic activity of Csk, as well as its Src homology (SH)3 and SH2 domains. Subsequent studies uncovered that, via its SH3 domain, p50csk was associated with PEP, a proline-enriched protein tyrosine phosphatase (PTP) of unknown function expressed in hemopoietic cells. Herein, we have attempted to identify the role of the Csk-PEP complex in T lymphocytes. The results of our experiments showed that, like Csk, PEP was a strong repressor of TCR signaling. This property was dependent on the phosphatase activity of PEP, as well as on the sequence mediating its binding to p50csk. Through reconstitution experiments in Cos-1 cells, evidence was obtained that Csk and PEP act synergistically to inhibit protein tyrosine phosphorylation by Src-related kinases, and that this effect requires their association. Finally, experiments with a substrate-trapping mutant of PEP suggested that PEP functions by dephosphorylating and inactivating the PTKs responsible for T-cell activation. In addition to giving novel insights into the mechanisms involved in the negative regulation of T-cell activation, these findings indicate that the association of an inhibitory PTK with a PTP constitutes a more efficient means of inhibiting signal transduction by Src family kinases in vivo.
- Open Access
- 1 August 1998
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 273 (35) , 22719-22728
High Expression of Inhibitory Receptor SHPS-1 and Its Association with Protein-tyrosine Phosphatase SHP-1 in Macrophages
- 1 August 1998
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 273 (35) , 22719-22728
Open AccessHigh Expression of Inhibitory Receptor SHPS-1 and Its Association with Protein-tyrosine Phosphatase SHP-1 in Macrophages